SCHEMBL8437356

SCHEMBL8437356

COC(=O)OC1=C(C)N(C)C(C)=C(C(C)=O)C1c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.42
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 1/20 0.38
MAPK1 P28482 1/20 0.38
MYLK Q15746 1/20 0.37
ELANE P08246 1/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9018579 0.87 MAPT (0.47) ADORA3TSHRNPSR1MEN1KMT2A
SCHEMBL8440174 0.83 TSHR (0.61) ADORA3TSHRHSD17B10KDM4EHPGD
SCHEMBL8438113 0.83 HPGD (0.60) TSHRHSD17B10KDM4EHPGDNPSR1
SCHEMBL8442358 0.83 TSHR (0.45) TSHRHSD17B10KDM4EHPGDNPSR1
SCHEMBL8441182 0.78 NPSR1 (0.44) TSHRHSD17B10KDM4EHPGDNPSR1
SCHEMBL9368993 0.76 ADORA3 (0.45) ADORA3MEN1KMT2AADRA2AADRA2B
SCHEMBL8438121 0.75 TSHR (0.41) TSHRHSD17B10KDM4EHPGDNPSR1
SCHEMBL9364563 0.75 SIRT6 (0.38) ADORA3TSHRHSD17B10KDM4EHPGD
SCHEMBL9367544 0.74 TSHR (0.47) TSHRHSD17B10KDM4EHPGDNPSR1
SCHEMBL10787692 0.73 KDM4E (0.51) ADORA3TSHRHSD17B10KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0717036-B1 Use of 5-acyl-1,4-dihydropyridines for the treatment of diseases of the CNS BAYER AG (DE) 1999-03-17 EP claimed
EP-0717036-A1 Use of 5-acyl-1,4-dihydropyridines for the treatment of diseases of the CNS BAYER AG (DE) 1996-06-19 EP claimed